Veeva Systems Inc. (VEEV) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $159.09. It has a SharesGrow Score of 83/100, indicating a strong investment profile with 6 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of VEEV = $303.33 (+90.7% from the current price, the stock appears undervalued). Analyst consensus target is VEEV = $280 (+76.1% upside).
Valuation: VEEV trades at a trailing Price-to-Earnings (P/E) of 29.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 2.57.
Financials: revenue is $3.2B, +14.1%/yr average growth. Net income is $909M, growing at +23.6%/yr. Net profit margin is 28.4% (strong). Gross margin is 75.5% (+3.8 pp trend).
Balance sheet: total debt is $96M against $7.2B equity (Debt-to-Equity (D/E) ratio 0.01, conservative). Current ratio is 4.89 (strong liquidity). Debt-to-assets is 1.1%. Total assets: $9.0B.
Analyst outlook: 29 / 42 analysts rate VEEV as buy (69%) — moderate consensus.
SharesGrow 7-Criteria breakdown: Value 51/100 (Partial), Growth 90/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 80/100 (Pass), Future 73/100 (Pass), Income 85/100 (Pass).
